Page 63 - ITPS-6-2
P. 63

INNOSC Theranostics and
            Pharmacological Sciences                                                    Tryptophan and schizophrenia



            psychopathological richness and the clinical characteristics,   Vittalle, 29: 44–56.
            such as its onset in adolescence and the deteriorating      https://doi.org/10.14295/vittalle.v29i2.6550
            course without major neurological alterations, arouse
            curiosity and generate a considerable number of studies on   2.   McCusker RH, Kavelaars A, Heijnen CJ,  et  al., 2014,
            the neurophysiological processes involved in the disease.   Depression, inflammation and tryptophan metabolism. In:
                                                                  The Wiley-blackwell Handbook of Psychoneuroimmunology.
            Furthermore, increased KYNA can have several important   Hoboken, New Jersey: Wiley, p448–468.
            adverse consequences  in schizophrenia.  Dysfunctions
            of  these  receptors  have  been  associated  with  cognitive      https://doi.org/10.1002/9781118314814.ch23
            impairments and symptom manifestations seen in people   3.   Menegatti R, Fraga CA, Barreiro EJ,  et al., 2004,
            with schizophrenia .                                  Schizophrenia: Forty years of the dopaminergic hypothesis
                           [3]
                                                                  from the perspective of medicinal chemistry. Quim Nova,
              Many advances have made it possible to better       27: 447–455.
            understand the pathophysiology of schizophrenia. However,
            much is yet to come. Several research groups around the      https://doi.org/10.1590/ s0100-40422004000300015
            world, using the wide array of methodologies, are working   4.   Madras BK, Cohen EL, Messing R, et al., 1974, Relevance
            hard to deepen our understanding of the processes involved   of free tryptophan in serum to tissue tryptophan
            in the disease. It is expected that the in-depth knowledge   concentrations. Metabolism, 23: 1107–1116.
            of the pathophysiological mechanisms involved will allow      https://doi.org/10.1016/0026-0495(74)90027-4
            the development of even more effective treatments for the
            control and eventually the prevention of schizophrenia.  5.   Curzon G, Friedel J, Knott PJ, 1974, The effect of fatty acids
                                                                  on the binding of tryptophan to plasma protein.  Nature,
            Acknowledgments                                       242: 198–200.
            None.                                                 https://doi.org/10.1038/242198a0
                                                               6.   Leblhuber F, Geisler S, Steiner K, et al., 2015, Elevated fecal
            Funding                                               calprotectin in patients with Alzheimer’s dementia indicates
                                                                  leaky gut. J Neural Transm (Vienna), 122: 1319–1322.
            None.
                                                                  https://doi.org/10.1007/s00702-015-1381-9
            Conflict of interest                               7.   Ruddick JP, Evans AK, Nutt DJ,  et  al., 2006, Tryptophan
            The authors declare that there are no conflicts of interest   metabolism in  the  central  nervous  system:  Medical
            that could be perceived as prejudicing the impartiality of   implications. Exp Rev Mol Med, 8: 1–27.
            the commentary.                                       https://doi.org/10.1017/S1462399406000068

            Author contributions                               8.   Reininghaus EZ, McIntyre RS, Reininghaus B, et al., 2014,
                                                                  Tryptophan breakdown is increased in euthymic overweight
            Conceptualization: Heberson Teixeira da Silva, Alessandro   individuals with bipolar disorder: A  preliminary report.
               Martins Ribeiro                                    Bipolar Disord, 16: 432–440.
            Writing – original draft: Dilceu Silveira Tolentino Júnior,      https://doi.org/10.1111/bdi.12166
               Thales Alexandre Ferreira-Aversi
            Writing – review & editing: Lízia Colares Vilela   9.   Anderson G, Jacob A, Bellivier F,  et al., 2016, Bipolar
                                                                  disorder: The role of the kynurenine and melatonergic
            Ethics approval and consent to participate            pathways. Curr Pharm Des, 22: 987–1012.
            Not applicable.                                       https://doi.org/10.2174/1381612822666151214105314
                                                               10.  Nguyen QT, Schroeder LF, Mank M, et al., 2010, An in vivo
            Consent for publication                               biosensor for neurotransmitter release and in situ receptor
            Not applicable.                                       activity. Nat Neurosci, 13: 127–134.
                                                                  https://doi.org/10.1038/nn.2469
            Availability of data
                                                               11.  Díaz-Marsa M, Lozano C, Herranz AS, et al., 2006, Acute
            Not applicable.                                       tryptophan depletion in eating disorders. Actas Esp Psiquiatr,
                                                                  34: 397–402.
            References
                                                               12.  Yang Y, Sauve AA, 2016, NAD(+) metabolism: Bioenergetics,
            1.   Carvalho MS, Mas CD, Nunes DF, et al., 2017, Tryptophan   signaling and manipulation for therapy.  Biochim Biophys
               metabolism in mental disorders: A focus on schizophrenia.   Acta, 1864: 1787–1800.


            Volume 6 Issue 2 (2023)                         4                         https://doi.org/10.36922/itps.0435
   58   59   60   61   62   63   64   65   66